As live donor medical charts are reviewed, certain birth tissue diseases may be encountered. This talk includes a brief introduction to the normal structure of the placenta and umbilical cord. Subsequently, the more common birth tissue abnormalities found in the medical charts will be discussed. The presentation will include many visual images, which are necessary to describe the birth tissue pathology. Donor eligibility and product suitability will be easier to determine with this enhanced knowledge of birth tissue pathology.

In an ever-evolving workplace landscape, organizations must be proactive in their approach to succession planning and talent management. This webinar will address the critical need for succession planning, explore various approaches, and provide strategies for effective communication. Additionally, we'll discuss how current workplace challenges and employee expectations present opportunities to integrate key components of talent and retention strategies, leverage an Employee Value Proposition (EVP), and foster a thriving organizational culture.

This webinar will address the regulatory and scientific considerations for allograft-based bone void filler regulated as devices under FDA's 510(k) pathway in the Center for Devices and Radiological Health (CDRH). Participants will be guided through the 510(k) pathway from product concept to marketing authorization and beyond, including when allograft-based bone void fillers would be considered a device under 510(k), what marketing claims are permissible for these devices, how to identify a predicate, and what types of testing are necessary. The webinar will also include how participants can obtain feedback related to their allograft-based bone void filler and best practices for interacting with FDA.

This webinar will address the regulatory and scientific considerations for allograft-based bone void filler regulated as devices under FDA's 510(k) pathway in the Center for Devices and Radiological Health (CDRH). Participants will be guided through the 510(k) pathway from product concept to marketing authorization and beyond, including when allograft-based bone void fillers would be considered a device under 510(k), what marketing claims are permissible for these devices, how to identify a predicate, and what types of testing are necessary. The webinar will also include how participants can obtain feedback related to their allograft-based bone void filler and best practices for interacting with FDA.

Save your staff time and money when you take advantage of the AATB Group Webinar Series Subscription. With one registration, your entire company will gain access to all AATB webinar programming for the whole year.

Take advantage of the AATB Individual Webinar Series Subscription providing individual access to an entire year of educational programming.